2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde

Pellegrino Musto; Monika Engelhardt; Jo Caers; Niccolo' Bolli; Martin  Kaiser; Niels W. C. J. van de Donk; Evangelos Terpos; Annemiek Broijl; Carlos Fernández de Larrea; Francesca Gay; Hartmut Goldschmidt; Roman Hajek; Annette Juul Vangsted; Elena Zamagni; Sonja Zweegman; Michele Cavo; Meletios A. Dimopoulos; Hermann Einsele; Heinz Ludwig; Giovanni Barosi; Mario Boccadoro; Maria Victoria Mateos; Pieter Sonneveld; Jesus San-Miguel

doi:10.3324/haematol.2021.278519

2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde

Pellegrino Musto
, Monika Engelhardt
, Jo Caers
, Niccolo' Bolli
, Martin Kaiser
, Niels W. C. J. van de Donk
, Evangelos Terpos
, Annemiek Broijl
, Carlos Fernández de Larrea
, Francesca Gay
, Hartmut Goldschmidt
, Roman Hajek
, Annette Juul Vangsted
, Elena Zamagni
, Sonja Zweegman
, Michele Cavo
, Meletios A. Dimopoulos
, Hermann Einsele
, Heinz Ludwig
, Giovanni Barosi

Mario Boccadoro, Maria Victoria Mateos, Pieter Sonneveld, Jesus San-Miguel

Hematology

Research output: Contribution to journal › Review article › Academic › peer-review

37 Citations (Scopus)

40 Downloads (Pure)

Abstract

According to the updated International Myeloma Working Group criteria, smoldering multiple myeloma (SMM) is an asymptomatic plasma cell disorder characterized by an M-component >3 g/dL, bone marrow plasma cell infiltration >10% and

Original language	English
Pages (from-to)	2799-2812
Journal	Haematologica
Volume	106
Issue number	11
Early online date	15 Jul 2021
DOIs	https://doi.org/10.3324/haematol.2021.278519
Publication status	Published - Nov 2021

Access to Document

10.3324/haematol.2021.278519Licence: CC BY-NC

Broijl_2021_European_Myeloma_Network_review_and_consensus_statement_on_smoldering_multiple_myeloma_how_to_distinguish.pdfFinal published version, 319 KBLicence: CC BY-NC

Cite this

Musto, P., Engelhardt, M., Caers, J., Bolli, N., Kaiser, M., van de Donk, N. W. C. J., Terpos, E., Broijl, A., Fernández de Larrea, C., Gay, F., Goldschmidt, H., Hajek, R., Vangsted, A. J., Zamagni, E., Zweegman, S., Cavo, M., Dimopoulos, M. A., Einsele, H., Ludwig, H., ... San-Miguel, J. (2021). 2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde. Haematologica, 106(11), 2799-2812. https://doi.org/10.3324/haematol.2021.278519

@article{d5bff05580114383a4faddc4b4106c67,

title = "2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde",

abstract = "According to the updated International Myeloma Working Group criteria, smoldering multiple myeloma (SMM) is an asymptomatic plasma cell disorder characterized by an M-component >3 g/dL, bone marrow plasma cell infiltration >10\% and ",

author = "Pellegrino Musto and Monika Engelhardt and Jo Caers and Niccolo' Bolli and Martin Kaiser and \{van de Donk\}, \{Niels W. C. J.\} and Evangelos Terpos and Annemiek Broijl and \{Fern{\'a}ndez de Larrea\}, Carlos and Francesca Gay and Hartmut Goldschmidt and Roman Hajek and Vangsted, \{Annette Juul\} and Elena Zamagni and Sonja Zweegman and Michele Cavo and Dimopoulos, \{Meletios A.\} and Hermann Einsele and Heinz Ludwig and Giovanni Barosi and Mario Boccadoro and Mateos, \{Maria Victoria\} and Pieter Sonneveld and Jesus San-Miguel",

year = "2021",

month = nov,

doi = "10.3324/haematol.2021.278519",

language = "English",

volume = "106",

pages = "2799--2812",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "11",

}

Musto, P, Engelhardt, M, Caers, J, Bolli, N, Kaiser, M, van de Donk, NWCJ, Terpos, E, Broijl, A, Fernández de Larrea, C, Gay, F, Goldschmidt, H, Hajek, R, Vangsted, AJ, Zamagni, E, Zweegman, S, Cavo, M, Dimopoulos, MA, Einsele, H, Ludwig, H, Barosi, G, Boccadoro, M, Mateos, MV, Sonneveld, P & San-Miguel, J 2021, '2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde', Haematologica, vol. 106, no. 11, pp. 2799-2812. https://doi.org/10.3324/haematol.2021.278519

TY - JOUR

T1 - 2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma

T2 - how to distinguish (and manage) Dr. Jekyll and Mr. Hyde

AU - Musto, Pellegrino

AU - Engelhardt, Monika

AU - Caers, Jo

AU - Bolli, Niccolo'

AU - Kaiser, Martin

AU - van de Donk, Niels W. C. J.

AU - Terpos, Evangelos

AU - Broijl, Annemiek

AU - Fernández de Larrea, Carlos

AU - Gay, Francesca

AU - Goldschmidt, Hartmut

AU - Hajek, Roman

AU - Vangsted, Annette Juul

AU - Zamagni, Elena

AU - Zweegman, Sonja

AU - Cavo, Michele

AU - Dimopoulos, Meletios A.

AU - Einsele, Hermann

AU - Ludwig, Heinz

AU - Barosi, Giovanni

AU - Boccadoro, Mario

AU - Mateos, Maria Victoria

AU - Sonneveld, Pieter

AU - San-Miguel, Jesus

PY - 2021/11

Y1 - 2021/11

N2 - According to the updated International Myeloma Working Group criteria, smoldering multiple myeloma (SMM) is an asymptomatic plasma cell disorder characterized by an M-component >3 g/dL, bone marrow plasma cell infiltration >10% and

AB - According to the updated International Myeloma Working Group criteria, smoldering multiple myeloma (SMM) is an asymptomatic plasma cell disorder characterized by an M-component >3 g/dL, bone marrow plasma cell infiltration >10% and

U2 - 10.3324/haematol.2021.278519

DO - 10.3324/haematol.2021.278519

M3 - Review article

C2 - 34261295

SN - 0390-6078

VL - 106

SP - 2799

EP - 2812

JO - Haematologica

JF - Haematologica

IS - 11

ER -

2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde

Abstract

Access to Document

Fingerprint

Cite this